A Population Perspective on Prevention of Dementia
- PMID: 31212802
- PMCID: PMC6617301
- DOI: 10.3390/jcm8060834
A Population Perspective on Prevention of Dementia
Abstract
The global number of people living with dementia is expected to increase to 130 million in 2050. Based on extensive evidence from observational studies, it is estimated that about 30% of dementia cases may be attributable to potentially modifiable risk factors. This suggests that interventions targeting these factors could perhaps delay or prevent the onset of dementia. Since the vast majority of people with dementia live in low- and middle-income countries, such interventions should preferably be easy and affordable to implement across a wide range of health care systems. However, to date, results from dementia prevention trials do not provide convincing evidence that treatment of these risk factors reduces the risk of dementia. The current paper aims to give an overview of available evidence for the potential for dementia prevention. In particular, we discuss methodological issues that might complicate the development of effective prevention interventions and explore the opportunities and challenges for future dementia prevention research. Currently, several ongoing and planned trials are testing the effect of multi-domain interventions on dementia risk in high-risk populations. It is desirable that future dementia strategies also target the wider population, through interventions on the individual, community, and population level, in order to constrain the growing prevalence of dementia worldwide.
Keywords: Alzheimer’s disease; dementia prevention; multi-domain interventions; public health; vascular risk factors.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatr. 1907;64:146–148.
-
- Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 1993;90:8098–8102. doi: 10.1073/pnas.90.17.8098. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources